Applications are now open for the AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020. Early-stage companies developing innovative technologies and programs in the field are encouraged to apply. Specific areas of interest include:
Technologies for non-viral cell transfection
Gene editing tools to create a universal host for allogeneic cells
Tools to measure cell surface markers
Closed processing Tools (not significant bottleneck)
